← All articles

Former Cowboys Player Posthumously Diagnosed with CTE After Death

Marshawn Kneeland, a Dallas Cowboys defensive end drafted in 2024, died by suicide in November 2025 and was posthumously diagnosed with Stage 1 CTE. The diagnosis highlights concerns about neurological safety in football, as CTE developed despite modern protocols. Research shows NFL players face significantly elevated risks for neurodegenerative conditions like ALS.

AI-assisted reporting

The essentials

Former Cowboys player posthumously diagnosed with CTE; condition linked to repeated head trauma and behavioral changes.

Marshawn Kneeland, a former Dallas Cowboys defensive end drafted in 2024, died by suicide in November 2025. Following his death, he was posthumously diagnosed with Stage 1 chronic traumatic encephalopathy (CTE), the neurodegenerative condition linked to repeated head trauma.

CTE is associated with behavioral symptoms including violent mood swings and depression. Kneeland's case underscores a persistent challenge in professional football: he developed CTE despite modern concussion protocols and improved safety equipment, raising questions about the adequacy of current protective measures.

The diagnosis adds to growing concerns about neurological health in football. NFL players are more than four times more likely to develop ALS than other men, according to research data. Kneeland began playing tackle football at age 7, accumulating decades of head impacts across youth, college, and professional levels before his death.

Broaden the view

Other ways to read this story.

Alternative framings generated by SigNews. These are not independent sources or attributed quotations.

Medical

CTE Diagnosis Reveals Limits of Current Safety Protocols

Kneeland's Stage 1 CTE diagnosis, despite modern equipment and concussion management, demonstrates that existing protective measures may be insufficient. CTE develops from accumulated sub-concussive impacts over years of play, beginning in youth football. The condition's association with mood disturbances and depression presents clinical questions about intervention and screening in active players.

Epidemiological

Data Shows Elevated Neurological Risk Across NFL Population

Kneeland's case reflects broader patterns: NFL players experience significantly higher rates of ALS and other neurodegenerative diseases compared to the general population. These findings suggest systemic exposure factors inherent to the sport rather than isolated incidents, pointing toward structural questions about long-term health outcomes across professional football careers.